Aviitam

Exposure

1 paper1 finding

  • 1 lab in 1 country
  • 1 of 1 finding with company ties
  • Humans1

Associations

1

Semaglutide

upin humans1OR 1.62

1 study
  1. Aviitam is associated with semaglutide in humans (adjusted OR 1.62, 95% CI 1.05-2.50).

    “each engagement increment was associated with higher odds of persistence (adjusted odds ratio 1.62, 95% CI 1.05-2.50; P=.03)”

    Humansinitiating semaglutide 2.4 mg/week for severe obesity48 weeksn = 191

    Digital Engagement and Predictors of Semaglutide Persistence and Weight Loss in Severe Obesity: 48-Week Observational Study

    Journal of medical Internet research26 Aug 2026

More on Semaglutide

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months